Abstract:A series of novel 1,3-bisubstituted and 1, 3,9-trisubstituted beta-carboline derivatives was synthesized from the starting material L-tryptophan. Cytotoxic activities of these compounds were investigated in vitro. The results showed that 1,3,9-trisubstituted beta-carboline derivatives had higher cytotoxic activities in vitro than the corresponding 1,3-bisubstituted compounds. Among all the synthesized 1,3,9-trisubstituted P-carboline derivatives, the compounds with a methyl substituent at position-1 displayed more potent cytotoxic activities, furthermore compound 5e having an ethoxycarbonyl substituent at position-3 and a pentafluorobenzyl at position-9, respectively, was found to be the most potent compounds of this series with IC50 value of 4 uM against BGC-823 cell lines. These data suggested that (1) the cytotoxic potencies of beta-carboline derivatives were enhanced by the introduction of appropriate substituents into position-1 and position-9 in beta-carboline; (2) the beta-carboline structure might be an important basis for the design and synthesis of new antitumor drugs; (3) the methyl substituent at position-1, the pentafluorobenzyl group at position-9 and the ethoxycarbonyl substituent at position-3 were the optimal combination for the improvement of cytotoxic activity of the P-carboline derivatives. (c) 2004 Elsevier SAS. All rights reserved.

Design, synthesis and mechanism of action of novel 1,9-disubstituted beta-carboline derivatives as antitumor agents

Design, Synthesis and Pharmacological Evaluation of Β-Carboline Derivatives As Potential Antitumor Agent Via Targeting Autophagy

Design, Synthesis, and Biological Evaluation of Novel Γ-Carboline Ketones As Anticancer Agents

Synthesis and biological evaluation of a novel class of beta-carboline derivatives

Design, synthesis and biological evaluation of novel β-carbolines as antitumor agents via targeting autophagy in colorectal cancer

Design, Synthesis, and Antitumor Activity of Β-Carboline- Benzimidazole Hybrids

Synthesis and Antitumor Activities of Β-Carboline Derivatives

Synthesis and biological evaluation of novel 3,9-substituted β-carboline derivatives as anticancer agents

Design, Synthesis, and Biological Evaluation of Novel N-Acylhydrazone Bond Linked Heterobivalent β-Carbolines as Potential Anticancer Agents

Design, Synthesis and in vitro Antitumor Activities of Novel Bivalent beta-Carbolines

Synthesis and in Vitro Cytotoxic Evaluation of Novel 3,4, 5-Trimethoxyphenyl Substituted Beta-Carboline Derivatives

Design, Synthesis, and Biological Evaluation of Novel N-γ-carboline Arylsulfonamides As Anticancer Agents.

Synthesis And Biological Evaluation Of Novel Tetrahydro-Beta-Carboline Derivatives As Antitumor Growth And Metastasis Agents Through Inhibiting The Transforming Growth Factor-Beta Signaling Pathway

Design, Synthesis and Biological Evaluation of Novel 2,4,6-Trisubstituted Quinazoline Derivatives As Potential Antitumor Agents

Synthesis and in Vitro Cytotoxic Evaluation of 1,3-Bisubstituted and 1,3,9-Trisubstituted Beta-Carboline Derivatives

Synthesis, Crystal Structure and Antitumor Activity of Novel 5-Chloro-β-carboline Derivatives

Synthesis and Biological Evaluation of Novel N9-heterobivalent Β-Carbolines As Angiogenesis Inhibitors

Design, Synthesis and Biological Activity Evaluation of β-Carboline Derivatives Containing Nitrogen Heterocycles

Design of Β-Carboline Derivatives As DNA-targeting Antitumor Agents

Synthesis and biological evaluation of novel bivalent beta-carbolines as potential antitumor agents

Design, Synthesis, Structure-Activity Relationships and Mechanism of Action of New Quinoline Derivatives As Potential Antitumor Agents